Review article
Inhalational anesthetics: Desflurane and sevoflurane

https://doi.org/10.1016/0952-8180(95)00129-8Get rights and content

Abstract

This article reviews the physico-chemical properties and performance characteristics of the two new potent inhaled anesthetics, desflurane and sevoflurane. Both drugs provide a greater degree of control of anesthetic depth and a more rapid immediate recovery from anesthesia than is currently available with other inhaled agents because of their decreased solubility.

Desflurane is currently in widespread clinical use in the United States and parts of Europe. Compared with sevoflurane, it has the additional advantage of being extremely resistant to degradation and biotransformation. However, its pungent odor and tendency to irritate the respiratory tract make it unsuitable for inhalational inductions, and it has been linked to CO production in CO2 absorbents. The sympathetic nervous system activation that occurs with desflurane limits its use in patients with cardiac disease. Otherwise, its hemodynamic and physiologic effects are similar to those seen with isoflurane. Studies of the economics of using desflurane are mixed, although it may offer the advantage of shorter postoperative recovery time.

Sevoflurane is currently in widespread clinical use in Japan and parts of South America. The FDA Advisory Panel has recently recommended approval of sevoflurane in the United States, and we can expect the drug to be clinically available in the United States in the second quarter of 1995. Compared with desflurane, sevoflurane has the additional advantage of being nonirritating to the airway; inhalational induction of anesthesia with sevoflurane is achieved rapidly and easily. The instability of sevoflurane with CO2 absorbents and its in vivo biotransformation produce potentially toxic byproducts. These byproducts, including Compound A and fluoride, have been extensively studied, and although the possibility for iatrogenic sequelae from sevoflurane exists, the likelihood of long-term toxicity appears quite low. Phase IV studies are indicated to determine the safety of administering sevoflurane (1) to renally impaired patients and (2) to any patient with fresh gas flows less than 2 L/min. Sevoflurane is otherwise very well tolerated and appears to offer the advantage of rapid and smooth induction and emergence from general anesthesia.

References (198)

  • E.I. Eger

    Stability of I-653 in soda lime

    Anesth Analg

    (1987)
  • D.D. Koblin et al.

    I-653 resists degradation in rats

    Anesth Analg

    (1988)
  • E.I. Eger et al.

    Studies of the toxicity of I-653, halothane, and isoflurane in enzyme-induced, hypoxic rats

    Anesth Analg

    (1987)
  • Z.X. Fang et al.

    Carbon monoxide production from degradation of desflurane, enflurane, and isoflurane, halothane, and sevoflurane by soda lime and Baralyme®

    Anesth Analg

    (1995)
  • R.K. Stoelting et al.
  • M.I. Gold et al.

    Minimum alveolar concentration of desflurane in patients older than 65 yr

    Anesthesiology

    (1993)
  • R.E. Kelly et al.

    Inhaled induction and emergence from desflurane anesthesia in the ambulatory surgical patient: the effect of premedication

    Anesth Analg

    (1993)
  • C.M. Bernards et al.

    Chronic cocaine administration does not alter desflurane MAC in the rat [Abstract]

    Anesthesiology

    (1994)
  • E.I. Eger et al.

    Rates of awakening from anesthesia with I-653, halothane, isoflurane, and sevoflurane: a test of the effect of anesthetic concentration and duration in rats

    Anesth Analg

    (1987)
  • L.G. Welborn et al.

    Comparison of emergence and recovery characteristics of sevoflurane, desflurane, and halothane in pediatric patients [Abstract]

    Anesth Analg

    (1995)
  • J.A. Nash et al.

    Desflurane and isoflurane induction rates using a closed circle system [Abstract]

    Anesthesiology

    (1994)
  • I Smith et al.

    Comparison of tracheal extubation in patients deeply anesthetized with desflurane or isoflurane

    Anesth Analg

    (1994)
  • R.B. Weiskopf et al.

    Rapid increase in desflurane concentration is associated with greater transient cardiovascular stimulation than with rapid increase in isoflurane concentration in humans

    Anesthesiology

    (1994)
  • P.J. Davis et al.

    Recovery characteristics of desflurane versus halothane for maintenance of anesthesia in pediatric ambulatory patients

    Anesthesiology

    (1994)
  • S.G. Graham et al.

    A comparison between propofol and desflurane anaesthesia for minor gynaecological laparoscopic surgery

    Anaesthesia

    (1993)
  • M.K. Rosenberg et al.

    Cost comparison: a desflurane- versus a propofol-based general anesthetic technique

    Anesth Analg

    (1994)
  • J.F. Szocik et al.

    A comparison of theoretical vs. actual cost of desflurane [Abstract]

    Anesthesiology

    (1994)
  • R.B. Weiskopf et al.

    Comparing the costs of inhaled anesthetics

    Anesthesiology

    (1993)
  • C.E. Smith et al.

    Does desflurane affect operating room turnover time in an ambulatory care unit? [Abstract]

    Anesthesiology

    (1994)
  • R.B. Weiskopf et al.

    Cardiovascular effects of I-653 in swine

    Anesthesiology

    (1988)
  • P.S. Pagel et al.

    Evaluation of myocardial contractility in the chronically instrumented dog with intact autonomic nervous system function: effects of desflurane and isoflurane

    Acta Anaesthesiol Scand

    (1993)
  • J.C. Hartman et al.

    Influence of desflurane, isoflurane, and halothane on regional tissue perfusion in dogs

    Can J Anaesth

    (1992)
  • R Mignella et al.

    Desflurane decreases collateral blood flow in a model of chronic coronary occlusion [Abstract]

    Anesthesiology

    (1994)
  • K Armbruster et al.

    Effects of desflurane on hemodynamics and oxygenation of liver and small intestine [Abstract]

    Anesthesiology

    (1994)
  • M.A. Moore et al.

    Arrhythmogenic doses of epinephrine are similar during desflurane or isoflurane anesthesia in humans

    Anesthesiology

    (1993)
  • J.D. Helman et al.

    The risk of myocardial ischemia in patients receiving desflurane versus sulfentanil anesthesia for coronary artery bypass graft surgery. The S.P.I. Research Group

    Anesthesiology

    (1992)
  • R.B. Weiskopf et al.

    Repetitive rapid increases in desflurane concentration blunt transient cardiovascular stimulation in humans

    Anesthesiology

    (1994)
  • W.T. Schmeling et al.

    The effects of isoflurane and desflurane on carotid baroreceptor afferent activity in dogs [Abstract]

    Anesth Analg

    (1995)
  • M.A. Moore et al.

    Rapid 1% increases of end-tidal desflurane concentration to greater than 5% transiently increase heart rate and blood pressure in humans

    Anesthesiology

    (1994)
  • O Carcoana et al.

    Desflurane vs. isoflurane following induction with propofol [Abstract]

    Anesthesiology

    (1994)
  • A Yonker-Sell et al.

    Desflurane produces greater sympathetic excitation than isoflurane during slow, controlled increases [Abstract]

    Anesth Analg

    (1995)
  • M Muzi et al.

    Lidocaine airway anesthesia does not attenuate sympathetic activation during desflurane administration [Abstract]

    Anesthesiology

    (1994)
  • A Devcic et al.

    The effects of clonidine on desflurane-mediated sympatho-excitation in humans [Abstract]

    Anesthesiology

    (1994)
  • RB Weiskopf et al.

    Fentanyl, esmolol, and clonidine blunt the transient cardiovascular stimulation induced by desflurane in humans

    Anesthesiology

    (1994)
  • TJ Ebert et al.

    The efficacy of propofol vs. etomidate in reducing desflurane-ediated sympathetic hyperactivity in humans [Abstract]

    Anesthesiology

    (1994)
  • J Kersten et al.

    Dexmedetomidine alters the hemodynamic effects of desflurane and isoflurane in chronically instrumented dogs

    Anesthesiology

    (1993)
  • GP Lu et al.

    Effect of desflurane on cerebral blood flow and microcirculation [Abstract]

    Anesthesiology

    (1994)
  • AA Artru et al.

    CSF, sagittal sinus, and jugular venous pressures during desflurane or isoflurane anesthesia in dogs

    J Neurosurg Anesthesiol

    (1994)
  • S Strebel et al.

    Dynamic and static autoregulation of cerebral blood flow velocity during isoflurane, desflurane, and propofol anesthesia [Abstract]

    Anesthesiology

    (1994)
  • AA Artru

    Intracranial volume/pressure relationship during desflurane anesthesia in dogs: comparison with isoflurane and thiopental/halothane

    Anesth Analg

    (1994)

    • Cited by (66)

    • Desflurane and sevoflurane differentially affect activity of the subthalamic nucleus in Parkinson's disease

      2021, British Journal of Anaesthesia

    • Evidence of noncovalent interactions between sevoflurane and dimethyl ether. FTIR cryospectroscopic and ab initio studies

      2020, Journal of Molecular Structure
      Citation Excerpt :

      Except methoxyflurane which revealed high nephrotoxicity, they gained a wide application in inhalation anesthesiology. Among these compounds, desflurane and sevoflurane belong to the most safety anesthetics for purposes of invasive surgery [1–3]. Although these compounds are known since the end of 20 century the nature of preferable mechanism of anesthetic effect still remains under discussion.

    • Short or moderate-time exposure to the inhalational anesthetics isoflurane and sevoflurane does not alter the marble-burying behavior in mice

      2020, Neuroscience Letters

    • Midazolam prevents sevoflurane-induced death in hippocampal neurons

      2019, Tissue and Cell
      Citation Excerpt :

      Sevoflurane is the most commonly used volatile anesthetics for both adults and children (Behne et al., 1999). Thus, sevoflurane is considered to be a safe agent for clinical purpose (Young and Apfelbaum, 1995). However, recent studies raised more concerns for the side effects caused by the sevoflurane exposure.

    • Desflurane reduces intraoperative remifentanil requirements more than sevoflurane: comparison using surgical pleth index-guided analgesia

      2018, British Journal of Anaesthesia
      Citation Excerpt :

      The two inhaled anaesthetics at 1.0 MAC did not show a similar intraoperative remifentanil consumption under SPI-guided analgesic administration. The rapid pharmacokinetics of sevoflurane and desflurane allowed the widespread clinical use of balanced anaesthesia in combination with short-acting opioid analgesics, such as remifentanil.1–5 However, over-administered opioid analgesics during surgery delay recovery from anaesthesia and cause opioid-related side effects.

    • Sevoflurane administration initiated out of the ED for life-threatening status asthmaticus

      2015, American Journal of Emergency Medicine
    View all citing articles on Scopus
    ∗

    Assistant Professor.

    †

    Associate Professor.

    View full text
    Copyright © 1995 Published by Elsevier Inc.